Upgrade to SI Premium - Free Trial

Amedisys (AMED) Tops Q3 EPS by 26c

October 29, 2019 4:09 PM
Amedisys (NASDAQ: AMED) reported Q3 EPS of $1.15, $0.26 better than the analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Earnings Guidance

Next Articles